Fisher Scientific International reported it's third quarter
performance for 2005, which revealed profit had more than doubled
as a result of improved sales and fewer acquisition related
charges.
The GEA Group has completed an agreement to acquire Steris's freeze
dryer (lyophiliser) product line, in a deal that aims to strengthen
the group's Process Engineering Division in the Process Engineering
Segment.
An affirmation that aims to replace the use of laboratory animals
in testing was agreed in Brussels by key industry sectors
representing the European chemical, pharmaceutical and
biotechnology industries.
A newly signed research and collaboration agreement between MFIC
Corporation and The University of Massachusetts Lowell (UML) will
facilitate the development of new applications, processes and
products in the growing area of nanomaterials.
pSivida has signed a licensing agreement with Beijing's Med-Pharm,
in a move that will facilitate distribution of BrachySil in China -
the world's fastest growing market for pharmaceuticals.
DSM announced that higher margins and lower fixed costs had boosted
operating profits by 44 per cent to €220 million in the third
quarter, with the performance materials and industrial chemicals
divisions leading the increase.
US consumers could have saved $20 billion (€16.6 billion) in 2004
and even more could be saved in future years by using more generic
drugs, according to a new report by Express Scripts.
Troubled firm Flamel reported a sharp decrease in total third
quarter revenues - $3.1 million (€2.6 million), compared to $13.3
million this time last year - resulting in a net loss $11.9
million.
A federal US judge set a precedent last week in ruling against the
US Food & Drug Administration (FDA) in a four-year dispute
against Utah Medical Products.
Merck announced last week a 57 per cent increase in third-quarter
net profit, reporting an operating result of €291 million, a 36 per
cent increase on last year.
The FDA is to extend its original review period for Exubera
(insulin (rDNA origin) powder for oral inhalation) by three months
to review additional technical chemistry data submitted by its
producers.
Penn Pharmaceutical Services has reported strong sales figures for
the fifth consecutive year, with a key driver of recent growth
being attributed to a boom in contract manufacturing as well as
small-scale commercial batches.
Cambrex has recorded a gain in the third quarter of this year, with
growth in its Bioproducts and Human Health segments. The company's
troublesome BioPharma division continues to underperform,
indicative of a market for outsourced...
Cardinal Health reported a varied first quarter, with sales and
income receiving substantial gains due to across-the-board
improvement in pharmaceutical distribution, medical products and
services and clinical technologies.
Arsenal Capital Partners has acquired a majority stake in Reilly
Industries for €209 million and Velsicol Chemical for an
undisclosed fee. The purchases continue a rich vein of activity for
the private equity firm, which now hold...
Millipore, a maker of purification systems used in drug
manufacturing, reported lower third-quarter profit due to
acquisition-related tax charges and manufacturing consolidation
costs.
Drug packaging maker West Pharmaceutical Services release its 3Q
results, which indicate a rise in profits but fell short of analyst
estimates, due to slow sales in some segments and high raw material
and energy costs.
EU environment ministers met on Monday to further debate key issues
related to the chemical substances review, which has become one of
the fiercest political battlegrounds ever in the history of EU
policy definition.
Bruker AXS, a subsidiary of the Bruker BioSciences Corporation, has
announced an agreement to purchase Roentec, an x-ray microanalysis
instrumentation company that signals Bruker's intention to
reinforce its standing within this...
Actavis's $810 million (€677 million) cash acquisition of
Alpharma's US and international generic drugs division is part of
the firm's strategy to become one of the global leaders in the
sector.
Dutch pharmaceuticals and chemicals giant Akzo Nobel reported
third-quarter sales of €3,29 billion, a slight decrease from the
previous quarter but up 5.4 per cent from the comparable period in
2004, thanks to growth in all its units,...
Chiron has warned it will yet again fall short of targets for its
US flu vaccine deliveries this year due to continuing production
problems with its British manufacturing plant.
Sterling Biotech, India's largest gelatin producer, has struck a
deal with Gujarat Biotech (TGBL) to purchase its manufacturing unit
for Rs 55 cr ($12.3 million) in an all cash deal. Sterling's
acquisition brings it one...
Bangledeshi's Beximco Pharmaceuticals has announced that the
company has raised $21 million after it successfully completed an
institutional placing of global depositary receipts (GDRs).
The GEA Group has acquired the manufacturer of freeze dryers for
pharmaceutical products, STERIS, a unit of US-based STERIS
Corporation in a deal that aims to strengthen the group's Process
Engineering Division in the Process...
BASF has announced it is to reduce production at one of its main
sites in a move that reflects the declining demand for
pseudoephedrine and caffeine caused by a change in prescription
regulations and pricing pressures.
Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing
at its US facility as part of its consolidation plans, which will
see the gradual phasing out of all operations at the New York
facility by late 2008.
The battle to gain control of UK filtration specialist Domnick Hunter took a dramatic turn after favourites to gain control, Eaton, admitted defeat, leaving rival bidder Parker Hannifin poised to complete the multimillion pound acquisition.
Innovation in targeted areas like nutrition should add sales worth
€1 billion in five years time, said vitamin and specialty chemicals
maker DSM today.
New rules detailing an improved format for prescription drug labels
will be issued later this year, US Food and Drug Administration
deputy commissioner for medical and scientific affairs Scott
Gottlieb has said.
The production capacity for biopharmaceutical manufacturing will
expand an average of 48 per cent over the next five years for
mammalian and microbial production systems, according to an
industry survey.
According to a new report, growing regulations in the European
pharmaceuticals industry is having a harmful effect on the market,
causing many companies to shift their bases to the United States
where the directives are more relaxed.
Animal activists' latest target in its campaign of terrorism has
centred on a chain of children's nurseries that has links with the
chemicals testing company, Huntingdon Life Sciences (HLS).
US biotechnology major Genzyme officially opened four European
facilities last week as part of a investment package eventually
expected to cost $540 million (€449m).
DecisionNews Media is seeking a further reporter for its
pharmaceuticals industry news services. Applicants must be
exceptionally bright, ambitious and talented, with experience in
news writing on the pharmaceuticals industry.
The US Food and Drug Administration (FDA) has found itself once
again without a permanent Commissioner after the current incumbent
- Lester Crawford - resigned after 18 months in the post.
The International Society of Pharmaceutical Engineers (ISPE) has
developed a definition of restricted access barrier systems, in
collaboration with the US Food and Drug Administration, in order to
clear up confusion in the pharmaceutical...
The US Food and Drug Administration (FDA) has drafted a current
Good Manufacturing Practice (cGMP) regulation for the production of
drugs used in positron emission tomography (PET), a diagnostic
tool.
Eisai has become the first Japanese drugmaker to set up a dedicated
subsidiary in India in order to tap into local expertise in
manufacturing and research, according to local press reports.
According to a recent report, pharmacogenetics is unlikely to
become a reality within the next 15-20 years having been 'hyped' by
the media, who are unaware of the many gaps in current
understanding of how genetics relates...
US generics company Andrx, currently in the throes of an
investigation into its manufacturing procedures by the Food and
Drug Administration, announced the resignation of chief financial
officer John Hanson.
The consolidation in the generic pharmaceutical industry continues
apace, with companies in the easterly reaches of Europe now getting
in on the act. Czech Republic-headquartered Zentiva has signed an
agreement to acquire 51 per cent...
Germany's Merck KGaA has laid out its plans to take on the market
for generic respiratory medicines, revealing that it is the
previously unnamed company that has licensed UK inhaler company
Innovata's Clickhaler device in...
Pharmaceutical companies are increasingly looking to retain their
internal focus on research and development (R&D) and marketing
while outsourcing their manufacturing processes, thus fueling a
growing demand for the manufacturing...
Sandoz, the generic drug unit of Swiss pharmaceutical group
Novartis, has filed a law suit against the US Food and Drug
Administration (FDA) alleging that the agency is dragging its feet
in a review of a 'biogeneric' drug...
A US think tank, The Centre for Medicines in the Public Interest,
has released a new report projecting counterfeit drug sales to
reach $75 billion in 2010, a 92 per cent increase from 2005.
US biotechnology company Biogen Idec has succumbed to the effects
of having to withdraw its multiple sclerosis drug Tysabri
(natalizumab) earlier this year, cutting 17 per cent of its
workforce and putting manufacturing facilities...